OSTEO-MEK Bone & Joint Support Tablets 30's

• Adults: Take one tablet three times daily with water, or as directed by a qualified homoeopathic practitioner, according to Mektum's published dosage instructions.
• This corresponds to three tablets daily when following the manufacturer's stated regimen.
• Use orally only.
• Take the tablets with water as directed.
• The manufacturer does not specify whether the tablets should be swallowed whole, chewed, or dissolved before swallowing.
• No specific administration interval relative to meals is provided in the manufacturer's accessible instructions.
• Follow the recommended frequency and treatment duration printed on the current product packaging.
• Do not exceed the recommended dosage.
• Children: Use only after professional paediatric advice and confirmation of age-appropriate manufacturer instructions.
• Pregnancy and breastfeeding: Avoid use unless a qualified healthcare professional has reviewed the complete formulation and specifically advised otherwise.
• Older adults: Seek medical advice before use, particularly when managing osteoporosis, recurrent fractures, osteoarthritis, or other chronic conditions.
• People with kidney disease: Consult the treating clinician before use because the complete mineral and botanical composition is unknown.
• People with kidney stones or disorders of calcium metabolism: Obtain professional advice before using an unverified bone-support formulation.
• People with inflammatory arthritis: Continue prescribed treatment and medical monitoring unless the treating clinician advises otherwise.
• People with osteoporosis: Do not replace prescribed bone-strengthening medicines, calcium, or vitamin D with OSTEO-MEK.
• Individuals taking anti-inflammatory medicines, corticosteroids, anticoagulants, osteoporosis medicines, or other regular treatments should consult a healthcare professional before combining preparations.
• Avoid combining multiple homoeopathic or herbal bone and joint supplements without reviewing their complete ingredients.
• Do not use prolonged or repeated courses without professional medical guidance.
• Discontinue use and seek medical advice if unexpected symptoms or suspected adverse reactions occur.
• Seek medical assessment for persistent pain, increased swelling, worsening stiffness, recurrent fractures, or reduced mobility.
• Seek urgent medical attention for severe pain following injury, visible deformity, inability to bear weight, or a painful swollen joint accompanied by fever.

Mektum's official product listing specifies one tablet three times daily with water, or as directed by a qualified homoeopathic practitioner. The manufacturer also advises users to read the label carefully, avoid excessive dosing, and seek professional advice during pregnancy, breastfeeding, or concurrent prescription medicine use.

The manufacturer does not provide a separate paediatric dosage, minimum recommended age, definitive tablet-administration method, or maximum treatment duration. These details should be confirmed against the current physical container, carton, or manufacturer-approved leaflet before publication.

Usage Information

OSTEO-MEK Bone & Joint Support Tablets may be incorporated into complementary homoeopathic care for traditionally described bone weakness, joint stiffness, reduced mobility, arthritis-related discomfort, and general musculoskeletal complaints. They are intended for oral use according to the manufacturer's instructions and should be accompanied by balanced nutrition, suitable physical activity, and professional medical care where necessary.

The preparation should not be expected to reliably reduce joint inflammation, regenerate damaged cartilage, improve bone mineral density, prevent fractures, reverse osteoporosis, or treat inflammatory arthritis. It must not replace prescribed medicines, physiotherapy, calcium or vitamin D supplementation when indicated, or established treatment for bone and joint disease.

Osteoarthritis is a common joint condition associated with pain, stiffness, and reduced physical function. It frequently affects the knees, hips, hands, and spine. Management may include therapeutic exercise, strengthening activities, appropriate weight management, and recommended pain-relief treatments.

Regular low-impact physical activity, such as walking, cycling, or swimming, may help maintain joint mobility and muscular strength. Resistance exercises can also support the muscles surrounding affected joints, helping maintain stability and physical function.

Exercise should be adapted to the individual's age, fitness, symptoms, and medical circumstances. Severe or rapidly worsening pain should not be ignored or attributed automatically to normal exercise-related soreness.

Osteoporosis is characterised by reduced bone strength and an increased risk of fractures. It may develop without noticeable symptoms until a fracture occurs. Older adults, postmenopausal women, and people with certain medical conditions or medication exposures may require fracture-risk assessment.

Adequate dietary calcium, appropriate vitamin D intake, suitable weight-bearing activity, resistance exercise, and fall-prevention measures contribute to bone-health management. Patients at elevated fracture risk may also require prescription medicines.

Dietary sources of calcium include milk, yoghurt, cheese, fortified foods, and selected vegetables. Vitamin D contributes to normal calcium absorption and bone mineralisation. However, OSTEO-MEK's calcium and vitamin D content has not been established, so it must not be relied upon to meet nutritional requirements.

Inflammatory arthritis, including rheumatoid arthritis, involves inflammation that may damage joints if inadequately treated. Persistent swelling, warmth, prolonged morning stiffness, and progressive joint symptoms require medical assessment. Disease-modifying medicines may be necessary for effective control.

Joint pain may also result from gout, injury, tendon disorders, infection, or other conditions. The appropriate treatment depends on the underlying cause and should not be determined solely by the presence of stiffness or discomfort.

Patients already receiving treatment for osteoporosis, osteoarthritis, rheumatoid arthritis, gout, or other musculoskeletal conditions should continue their prescribed care unless their treating clinician advises otherwise.

Individuals with recurrent falls, unexplained fractures, persistent back pain, reduced height, or suspected bone weakness may require assessment for osteoporosis or other skeletal disorders.

For people recovering from musculoskeletal injury, the timing of activity and rehabilitation should be guided by the nature of the injury. A homoeopathic bone-support preparation cannot replace fracture immobilisation, surgical treatment when indicated, or structured rehabilitation.

Because the manufacturer's ingredient composition is unpublished, people taking regular medicines should seek professional advice before using OSTEO-MEK. Its potential interactions cannot be excluded without complete formulation details.

Persistent joint pain, recurrent swelling, worsening stiffness, reduced mobility, muscle weakness, numbness, or pain interfering with everyday activities requires professional medical assessment.

A hot, swollen, severely painful joint accompanied by fever requires urgent medical attention, as it may indicate septic arthritis or another serious inflammatory condition.

Severe pain following a fall, visible deformity, inability to bear weight, sudden limb weakness, or loss of sensation also requires prompt medical assessment. Severe back pain accompanied by new bladder or bowel dysfunction or numbness around the groin requires emergency care.

OSTEO-MEK Tablets should not be used to delay diagnosis or treatment of osteoporosis, osteoarthritis, rheumatoid arthritis, gout, fractures, bone infections, autoimmune conditions, or other underlying musculoskeletal disorders.

Storage Instructions

Store OSTEO-MEK Bone & Joint Support Tablets tightly closed in their original 30-tablet container in a cool, dry place away from direct sunlight, excessive heat, moisture, and strong odours. Follow any specific storage temperature instructions printed on the current manufacturer-approved packaging. Protect the tablets from humidity and avoid storing them in bathrooms or other damp environments where moisture may affect their physical stability. Keep the container securely out of the sight and reach of children, and do not transfer the tablets into an unlabelled container. Do not use after the expiry date or if the container is damaged, the seal is compromised, or the tablets show unusual changes in colour, appearance, texture, or odour. Handle the tablets with clean, dry hands, avoid introducing moisture into the container, and close it securely after each use. Retain the original container, carton, and manufacturer-approved leaflet for confirmation of the exact active-ingredient names, homoeopathic potencies, quantitative formulation, elemental mineral content, tablet excipients, sugar and allergen status, age-specific dosage instructions, storage requirements, precautions, and market-specific product information.